Mark A. Dominick

1.0k total citations
29 papers, 648 citations indexed

About

Mark A. Dominick is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Mark A. Dominick has authored 29 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in Mark A. Dominick's work include Peroxisome Proliferator-Activated Receptors (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cholesterol and Lipid Metabolism (4 papers). Mark A. Dominick is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cholesterol and Lipid Metabolism (4 papers). Mark A. Dominick collaborates with scholars based in United States and Germany. Mark A. Dominick's co-authors include F Marcoux, R. B. Rimler, John R. MacDonald, Thomas P. Sanderson, Alec W. Gough, Sarah H. Tannehill‐Gregg, James F. Reindel, Edward J. McGuire, Samuel M. Cohen and Grushenka H.I. Wolfgang and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Mark A. Dominick

29 papers receiving 593 citations

Peers

Mark A. Dominick

SURGE

EDM

ONCOL

Gerd Reznik Germany

Sandrine Marie Belgium

Susan J. Nishio United States

Ingeborg Løstegaard Goverud Norway

Paško Konjevoda Croatia

Chandikumar S. Elangbam United States

J. P. Filkins United States

Toshiki Sudo Japan

Dong-Ju Shin United States

Anne M. Karinch United States

Gerd Reznik Germany

Mark A. Dominick

164 ×0.6

72 ×0.4

SURGE

138 ×1.3

32 ×0.4

EDM

80 ×1.3

ONCOL

Citations per year, relative to Mark A. Dominick Mark A. Dominick (= 1×) peers Gerd Reznik

Countries citing papers authored by Mark A. Dominick

Since Specialization

Citations

This map shows the geographic impact of Mark A. Dominick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Dominick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Dominick more than expected).

Fields of papers citing papers by Mark A. Dominick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Dominick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Dominick. The network helps show where Mark A. Dominick may publish in the future.

Co-authorship network of co-authors of Mark A. Dominick

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Dominick. A scholar is included among the top collaborators of Mark A. Dominick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Dominick. Mark A. Dominick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tannehill‐Gregg, Sarah H., et al.. (2009). Dietary ammonium chloride for the acidification of mouse urine.. PubMed. 48(2). 144–6. 6 indexed citations

Tannehill‐Gregg, Sarah H., Mark A. Dominick, David Stock, et al.. (2009). Strain-related Differences in Urine Composition of Male Rats of Potential Relevance to Urolithiasis. Toxicologic Pathology. 37(3). 293–305. 20 indexed citations

Tannehill‐Gregg, Sarah H., Thomas P. Sanderson, Daniel J. Minnema, et al.. (2007). Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR α and γ Agonist Muraglitazar. Toxicological Sciences. 98(1). 258–270. 39 indexed citations

Dominick, Mark A., et al.. (2007). Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist. Toxicological Sciences. 100(1). 248–258. 27 indexed citations

Vleet, Terry R. Van, Thomas P. Sanderson, Samuel M. Cohen, et al.. (2006). Subchronic Urinary Bladder Effects of Muraglitazar in Male Rats1. Toxicological Sciences. 96(1). 58–71. 15 indexed citations

Reindel, James F., et al.. (1994). Toxicologic Effects of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor in Cynomolgus Monkeys. Toxicologic Pathology. 22(5). 510–518. 31 indexed citations

Vernetti, Lawrence A., et al.. (1993). ATP Depletion Is Associated with Cytotoxicity of a Novel Lipid Regulator in Guinea Pig Adrenocortical Cells. Toxicology and Applied Pharmacology. 118(1). 30–38. 41 indexed citations

Dominick, Mark A.. (1993). Subacute Toxicity of a Novel Inhibitor of Acyl-CoA: Cholesterol Acyltransferase in Beagle Dogs. Fundamental and Applied Toxicology. 20(2). 217–224. 57 indexed citations

Marcoux, F, Mark L. Weber, Albert W. Probert, & Mark A. Dominick. (1992). Hypoxic Neurodegeneration in Culture: Calcium Influx, Electron Microscopy, and Neuroprotection with Excitatory Amino Acid Antagonists. Annals of the New York Academy of Sciences. 648(1). 303–305. 5 indexed citations

10.

MacDonald, John R., et al.. (1992). Renal Structure and Function in Rats After Suprapharmacologic Doses of Quinapril, an Angiotensin-Converting Enzyme Inhibitor. Journal of Cardiovascular Pharmacology. 19(2). 282–289. 10 indexed citations

11.

Dominick, Mark A.. (1991). ?2u-Globulin nephropathy without nephrocarcinogenesis in male Wistar rats administered 1-(aminomethyl)cyclohexaneacetic acid. Toxicology and Applied Pharmacology. 111(3). 375–387. 26 indexed citations

12.

Dominick, Mark A., et al.. (1990). Ultrastructural Juxtaglomerular Cell Changes in Normotensive Rats Treated with Quinapril, an Inhibitor of Angiotensin-Converting Enzyme. Toxicologic Pathology. 18(3). 396–406. 12 indexed citations

13.

Dominick, Mark A., Walter F. Bobrowski, & Alan Metz. (1990). Proliferative Exocrine Pancreatic Lesions in Aged Wistar Rats. Toxicologic Pathology. 18(3). 423–426. 4 indexed citations

14.

Marcoux, F, et al.. (1988). Ketamine prevents ischemic neuronal injury. Brain Research. 452(1-2). 329–335. 81 indexed citations

15.

Dominick, Mark A. & R. B. Rimler. (1988). Turbinate Osteoporosis in Pigs Following Intranasal Inoculation of Purified Pasteurella Toxin: Histomorphometric and Ultrastructural Studies. Veterinary Pathology. 25(1). 17–27. 32 indexed citations

16.

Dominick, Mark A. & R. B. Rimler. (1986). Turbinate atrophy in gnotobiotic pigs intranasally inoculated with protein toxin isolated from type D Pasteurella multocida. American Journal of Veterinary Research. 47(7). 1532–1536. 15 indexed citations

17.

Dominick, Mark A., Mary Jo Schmerr, & A. E. Jensen. (1985). Expression of type 1 pili by Escherichia coli strains of high and low virulence in the intestinal tract of gnotobiotic turkeys. American Journal of Veterinary Research. 46(1). 270–275. 7 indexed citations

18.

Dominick, Mark A. & N. F. Cheville. (1985). Pathology of Cloacal Bursae of Gnotobiotic Turkeys Orally Inoculated withEscherichia coli. Veterinary Pathology. 22(3). 262–271. 3 indexed citations

19.

Dominick, Mark A. & A. E. Jensen. (1984). Colonization and persistence of Escherichia coli in axenic and monoxenic turkeys. American Journal of Veterinary Research. 45(11). 2331–2335. 5 indexed citations

20.

Dominick, Mark A. & Thomas L. Carson. (1983). Effects of carbon monoxide exposure on pregnant sows and their fetuses. American Journal of Veterinary Research. 44(1). 35–40. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact